“…4). Early studies before receptor identification, showed that treatment with relaxin increased cAMP accumulation in THP-1 cells (Parsell et al, 1996), MCF-7 cells (Bigazzi et al, 1992), the mouse pubic symphysis (Braddon, 1978), uterine strips (Sanborn et al, Relaxin Family Peptide Receptors 1980), uterine longitudinal muscle (Osa et al, 1991) from estrogen-primed rats, and in cultures of human endometrial cells (Fei et al, 1990), human endometrial glandular epithelial cells (Chen et al, 1988), newborn rhesus monkey uterine cells (Kramer et al, 1990), rat myometrial cells (Hsu et al, 1985), and rat anterior pituitary cells (Cronin et al, 1987). The importance of cAMP as a signaling pathway for relaxin was confirmed on RXFP1 deorphanization, because constitutively active mutants of RXFP1 (TM6: D637Y) increased cAMP accumulation in a ligandindependent manner (Hsu et al, 2000.…”